You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Biomarker Testing

Find an overview of funded biomarker testing in Ontario. Information listed includes diagnostic, predictive and prognostic markers, as well as a summary of testing sites.

Disponible en anglais seulement. Vous pouvez demander un version française.

Funded Biomarker Testing

5 items

Immunohistochemical evaluation, where indicated, to assess line of differentiation for classification

Funded Biomarker Disease Site: Soft Tissue
Biomarker:
Testing Method:Immunohistochemistry (IHC)
Testing Site: Hamilton Health Sciences, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, The Ottawa Hospital

Molecular interrogation, where indicated, for classification, prognostic and/or therapeutic purposes.

Funded Biomarker Disease Site: Soft Tissue
Biomarker: Refer to 2023 Consensus Pathology Recommendations for Mesenchymal Tumours of Soft Tissue and Bone
Testing Method:Sequencing
Testing Site: Mount Sinai Hospital, The Ottawa Hospital

Reflex testing on newly diagnosed CD117 (cKIT) positive Gastrointestinal Stromal Tumours

Funded Biomarker Disease Site: Soft Tissue
Biomarker: BRAF, KIT, PDGFRA (Optional 23/24 - SDH, NTRK (fusion))
Testing Method:Sequencing
Testing Site: Hamilton Health Sciences, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, University Health Network

Reflex testing on newly diagnosed CD117 (cKIT) positive Gastrointestinal Stromal Tumours

Funded Biomarker Disease Site: Soft Tissue
Biomarker: SDHB
Testing Method:Immunohistochemistry (IHC)
Testing Site: London Health Sciences Centre, Mount Sinai Hospital

Review of tumour by a subspecialist Pathologist for classification

Funded Biomarker Disease Site: Soft Tissue
Biomarker:
Testing Method:
Testing Site: Hamilton Health Sciences, Mount Sinai Hospital, The Ottawa Hospital